Mouse Anti-KDM3B Recombinant Antibody (CBLXK-003) (CBMAB-2208CQ)

D’Amore, C., Borgo, C., Bosello Travain, V., & Salvi, M. (2022). KDM2A and KDM3B as Potential Targets for the Rescue of F508del-CFTR. International Journal of Molecular Sciences, 23(17), 9612.

Zhu, Z., Wu, X., Li, Q., Zhang, J., Yu, S., Shen, Q., ... & Hua, J. (2021). Histone demethylase complexes KDM3A and KDM3B cooperate with OCT4/SOX2 to define a pluripotency gene regulatory network. The FASEB Journal, 35(6), e21664.

Wang, Y., Zhao, Y., Wang, H., Zhang, C., Wang, M., Yang, Y., ... & Hu, Z. (2020). Histone demethylase KDM3B protects against ferroptosis by upregulating SLC7A11. FEBS Open Bio, 10(4), 637-643.

Saraç, H., Morova, T., Pires, E., McCullagh, J., Kaplan, A., Cingöz, A., ... & Lack, N. A. (2020). Systematic characterization of chromatin modifying enzymes identifies KDM3B as a critical regulator in castration resistant prostate cancer. Oncogene, 39(10), 2187-2201.

Zhang, C., Han, X., Liang, Y., Liu, H., Fan, Z., & Zhang, J. (2020). The histone demethylase KDM3B promotes osteo-/odontogenic differentiation, cell proliferation, and migration potential of stem cells from the apical papilla. Stem Cells International, 2020.

Jung, H., & Seo, S. B. (2020). Histone lysine demethylase 3B (KDM3B) regulates the propagation of autophagy via transcriptional activation of autophagy-related genes. Plos one, 15(7), e0236403.

An, M. J., Kim, D. H., Kim, C. H., Kim, M., Rhee, S., Seo, S. B., & Kim, J. W. (2019). Histone demethylase KDM3B regulates the transcriptional network of cell-cycle genes in hepatocarcinoma HepG2 cells. Biochemical and biophysical research communications, 508(2), 576-582.

Diets, I. J., van der Donk, R., Baltrunaite, K., Waanders, E., Reijnders, M. R., Dingemans, A. J., ... & Jongmans, M. C. (2019). De novo and inherited pathogenic variants in KDM3B cause intellectual disability, short stature, and facial dysmorphism. The American Journal of Human Genetics, 104(4), 758-766.

Wang, X., Fan, H., Xu, C., Jiang, G., Wang, H., & Zhang, J. (2019). KDM3B suppresses APL progression by restricting chromatin accessibility and facilitating the ATRA-mediated degradation of PML/RARα. Cancer Cell International, 19(1), 1-15.

Xu, X., Nagel, S., Quentmeier, H., Wang, Z., Pommerenke, C., Dirks, W. G., ... & Hu, Z. (2018). KDM3B shows tumor-suppressive activity and transcriptionally regulates HOXA1 through retinoic acid response elements in acute myeloid leukemia. Leukemia & lymphoma, 59(1), 204-213.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols